1 results match your criteria: "Empire Centre Haemotology & Oncology Speciality Clinic[Affiliation]"
Current Perspective on Use of NOAC in Clinical Practice in India.
J Assoc Physicians India
April 2016
Empire Centre Haemotology & Oncology Speciality Clinic, Mumbai.
Article Synopsis
- Oral vitamin K antagonists like warfarin have been commonly used for stroke prevention in NVAF patients but have significant risks, including bleeding and a narrow therapeutic window.
- Novel oral anticoagulants (NOACs), such as dabigatran, rivaroxaban, and apixaban, offer effective alternatives with benefits like quick action and less need for monitoring.
- The article discusses practical considerations for NOAC therapy in India, including monitoring anticoagulant effects, transitioning between medications, ensuring compliance, managing dosing errors, and addressing bleeding complications, based on European guidelines.